CANCER WITH A HIGH TUMOUR MUTATIONAL BURDEN

CANCER WITH A HIGH TUMOUR MUTATIONAL BURDEN was reported 39 times

CANCER WITH A HIGH TUMOUR MUTATIONAL BURDEN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen Receptor Antagonist [EPC] 5 0.0001
1 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 2 0.0001
2 Programmed Death Ligand-1 Blocker [EPC] 2 0.0001
3 CTLA-4-directed Blocking Antibody [EPC] 4 0.0001
4 Radioligand Therapeutic Agent [EPC] 1 0.0001
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 6 0.0001
6 Aromatase Inhibitor [EPC] 5 0.0000
7 HER2/neu Receptor Antagonist [EPC] 3 0.0000
8 Microtubule Inhibitor [EPC] 6 0.0000
9 Provitamin D2 Compound [EPC] 1 0.0000
10 BCL-2 Inhibitor [EPC] 2 0.0000
11 Platinum-based Drug [EPC] 8 0.0000
12 Alkylating Drug [EPC] 6 0.0000
13 Nucleoside Metabolic Inhibitor [EPC] 5 0.0000
14 alpha-Adrenergic Blocker [EPC] 2 0.0000
15 Arteriolar Vasodilator [EPC] 1 0.0000
16 Kinase Inhibitor [EPC] 6 0.0000
17 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
18 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
19 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
20 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
21 beta-Adrenergic Blocker [EPC] 2 0.0000
22 Aldosterone Antagonist [EPC] 1 0.0000
23 Azole Antifungal [EPC] 1 0.0000
24 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
25 Thiazide Diuretic [EPC] 1 0.0000
26 Osmotic Laxative [EPC] 1 0.0000
27 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
28 Benzodiazepine [EPC] 1 0.0000
29 Corticosteroid [EPC] 1 0.0000